Article
Anaheim, CA-Frequency-doubling technology (FDT), a relatively new rapid screen test for glaucoma, may also be useful for following patients with glaucoma.
Alcon agrees to purchase LENSAR
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
ZEISS VISULAS Combi availability expands to Canada
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial
Importance of evaluating cerebrospinal fluid at vitreoretinal lymphoma diagnosis